Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open Label Expanded Access for Investigational Use of PV-10 in Patients Who Are Not Eligible for an Existing PV-10 Clinical Trial, for Whom There is no Alternative Therapy, and Whom May Benefit From PV-10 Administration

Next Previous
Search
Trial Profile

Open Label Expanded Access for Investigational Use of PV-10 in Patients Who Are Not Eligible for an Existing PV-10 Clinical Trial, for Whom There is no Alternative Therapy, and Whom May Benefit From PV-10 Administration

Status: Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 29 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rose bengal sodium (Primary)
  • Indications Solid tumours
  • Focus Expanded access; Therapeutic Use
  • Sponsors Provectus Biopharmaceuticals

Most Recent Events

  • 27 Sep 2021 According to Provectus Biopharmaceuticals media release, data from this study will be presented on two poster presentations at the SMR 2021 Congress (the Society for Melanoma Research annual meeting).
  • 08 Jul 2016 Status changed from recruiting to completed.
  • 24 Nov 2010 As of 24 November 2010, over 40 patients have been enrolled in this compassionate use programme according to a Provectus Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top